Large-scale testing (Phase 3)Study completedNCT01602380
What this trial is testing
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
Who this might be right for
Hormone Receptor Positive Breast Cancer
AstraZeneca 462